首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1390731

家禽疫苗市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Poultry Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球家禽疫苗市場規模達18億美元。展望未來， IMARC Group預計到2028年市場規模將達到26億美元，2022-2028年複合年成長率（CAGR）為6.32%。家禽疾病預防意識的增強、對安全無病家禽產品的需求不斷增加以及疫苗開發技術的不斷進步以確保永續生產是推動市場成長的主要因素。

家禽疫苗是專門用於保護家禽（例如雞、鴨和火雞）免受傳染病侵害的生物製品。它的配方可以觸發鳥類的免疫反應，使它們能夠對特定病原體（包括病毒和細菌）產生免疫力。疫苗接種過程可以透過不同的途徑進行，例如注射、氣霧劑或透過鳥類的飲用水進行。疫苗接種計劃是根據一個地區流行的特定疾病風險量身定做的，是家禽養殖場生物安全措施的一個組成部分。此外，農民可以透過使用適當的家禽疫苗，有效減輕疾病爆發並確保家禽產品的永續和安全生產。如今，家禽疫苗對於維持家禽族群的健康和福祉至關重要。

該市場主要受到生物製品需求不斷成長的推動。此外，對肉類和雞蛋等家禽產品的需求不斷增加，導致家禽產量增加，從而影響了市場成長。與此相適應，不斷成長的家禽數量需要使用疫苗來保護家禽並維持生產水平，從而促進市場成長。此外，家禽養殖戶和生產者越來越意識到預防性醫療措施（包括疫苗接種）的重要性，以確保其雞群的福祉和生產力，這是另一個主要的成長誘導因素。除此之外，疫苗接種被認為是控制和預防傳染病傳播的一種經濟有效的方法，減少對抗生素和其他治療的需求，從而推動市場成長。除此之外，強調食品安全和動物福利重要性的多項政府政策的實施正在加速市場成長。此外，疫苗技術和研究的進步導致了更有效和更有針對性的疫苗的開發，提高了其功效和安全性，從而創造了積極的市場前景。

家禽疫苗市場趨勢/促進因素：

家禽消費不斷增加

對雞肉、肉類和雞蛋等家禽產品的需求不斷成長正在影響市場的成長。此外，人口的成長、都市化的快速發展、人們忙碌的生活方式正在不斷增加對家禽產品的需求，從而促進了市場的成長。此外，家禽養殖戶正在將疫苗接種作為預防措施，以保護其雞群並確保穩定供應安全無病的產品，這是另一個主要的生長誘導因素。除此之外，疫苗提供了一種有效且高效的方法來保護家禽免受傳染病的侵害，減少疫情爆發和相關生產損失的可能性，從而加速市場成長。除此之外，農民還可以提高家禽健康和生產力，透過免疫雞群來提高家禽業的效率和獲利能力，從而推動市場成長。除此之外，家禽消費的成長導致家禽和家禽產品的國際貿易增加，進而推動市場成長。

疾病預防意識不斷增強

家禽中傳染病發病率的不斷上升導致農民和生產者廣泛採用疫苗來實施預防措施來保護其雞群，從而影響市場成長。此外，農民擴大投資於疫苗接種計劃，以保障其投資、控制疾病並幫助減少家禽傳染病的發生率和嚴重程度，這是另一個主要的成長誘導因素。除此之外，農民還可以防止疾病傳播並最大程度地減少生產損失，透過對雞群進行免疫確保持續供應健康的家禽產品，以滿足消費者的需求，從而加速市場成長。同時，人們對健康意識的增強和對安全優質食品的需求不斷增加，有助於在疫苗的幫助下生產安全衛生的家禽產品，從而推動市場成長。此外，消費者對疫苗接種家禽益處的認知不斷增強，進一步推動了對家禽疫苗的需求，鼓勵生產商將疫苗接種作為其疾病預防策略的一個重要方面。

疫苗開發的新興技術進步

現代疫苗的開發可以生產出效力更高、免疫力更持久的疫苗，為多種家禽疾病提供更好的保護，進而促進市場成長。此外，生物技術、創新方法和技術的不斷發展正在催生更有效、更安全和更有針對性的家禽疫苗，這是另一個主要的生長誘導因素。除此之外，佐劑和載體疫苗、家禽疫苗等疫苗傳遞系統的廣泛進步現在可以引發更強大和特異性的免疫反應，從而加速市場成長。同時，這些突破導致了客製化疫苗的開發，可以滿足各種家禽品種的特定需求和區域疾病挑戰，從而推動市場成長。此外，疫苗配方的進步導致生產出更穩定和耐溫的疫苗，延長了其保存期限並減少了冷鏈儲存和運輸的需求，從而使家禽養殖戶更容易分發和獲得疫苗，特別是在偏遠或資源豐富的地區-受限地區，從而創造積極的市場前景。

家禽疫苗行業細分：

IMARC Group提供了全球家禽疫苗市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據疾病、產品、劑型、應用和最終用戶對市場進行了分類。

因疾病而分手：

傳染性支氣管炎

禽流感

新城疫

馬立克氏症

其他

新城疫是最常見的疾病

該報告根據疾病提供了詳細的市場細分和分析。這包括傳染性支氣管炎、禽流感、新城疫、馬立克氏症等。報告稱，新城疫佔據了最大的市場佔有率。

新城疫（ND）是一種高度傳染性的病毒性疾病，影響多種禽類，包括雞、火雞和鴿子，對家禽業帶來嚴重的經濟損失。此外，新城疫因其快速傳播和對家禽群的破壞性影響而成為家禽養殖戶和生產者的主要擔憂，從而影響市場成長。此外，新城疫的爆發可能導致高死亡率、產蛋量減少和飼料轉換效率降低，對家禽業帶來巨大的經濟損失，進而促進市場成長。除此之外，疫苗接種對於家禽生產者的預防措施至關重要，有助於增強對病毒的免疫力，降低感染的嚴重程度，並最大限度地減少疾病在雞群中的傳播，從而推動市場成長。除此之外，定期、及時地對家禽進行疫苗接種對於預防新城疫爆發和保持雞群健康至關重要，從而加速市場成長。除此之外，家禽養殖戶依靠這些疫苗來確保雞群的健康，確保投資，並維持無病家禽產品的穩定供應，以滿足消費者的需求，從而為市場成長提供積極的推動力。

按產品分類：

重組疫苗

減毒活疫苗

去活化疫苗

亞單位疫苗

其他

減毒活疫苗是最受歡迎的產品

該報告根據產品提供了詳細的市場細分和分析。這包括重組疫苗、減毒活疫苗、不活化疫苗、次單位疫苗等。報告稱，減毒活疫苗佔據最大的市場佔有率。

減毒活疫苗是由弱化形式的病原體開發而成，保留了在宿主體內誘導免疫反應的能力，而不引起嚴重疾病，有助於市場成長。此外，減毒活疫苗在提供針對多種家禽疾病的持久免疫力方面具有卓越功效，進而影響市場成長。這些疫苗引發體液和細胞介導的免疫反應，為家禽群提供強而有力的保護。此外，減毒活疫苗模仿自然感染，產生全面、持續的免疫防禦，可以治療多種家禽疾病，包括禽流感、新城疫和傳染性支氣管炎，這是另一個主要的生長誘導因素。除此之外，減毒活疫苗針對不同病原體菌株提供交叉保護的能力增加了它們對家禽養殖戶和生產者的吸引力，加速了市場成長。除了功效之外，減毒活疫苗通常具有成本效益，使其成為大規模家禽生產的有吸引力的選擇，從而推動市場成長。

按劑型分類：

液體疫苗

凍乾疫苗

液體疫苗目前佔據最大的市場佔有率

該報告根據劑型對市場進行了詳細的細分和分析。這包括液體疫苗和冷凍乾燥疫苗。報告稱，液體疫苗佔據最大的市場佔有率。

液體疫苗以其易於給藥而聞名，可以透過飲用水或皮下或肌肉注射來輸送，使疫苗接種過程更加簡單和高效。此外，在對大型雞群進行疫苗接種時，管理的簡單性尤其重要，因為它可以最大限度地減少疫苗接種程序所需的時間和精力，從而促進市場成長。此外，液體疫苗在劑量方面具有更好的均勻性和一致性，它們在疫苗溶液中充分混合，確保每隻雞接受準確且均勻劑量的疫苗，這是另一個主要的生長誘導因素。這種一致性對於在整個家禽群中實現最佳免疫水平和最大限度地提高疫苗效力至關重要。

除此之外，液體疫苗比其他劑型更具成本效益，因為它的製造成本較低，而且其有效的管理減少了對專用設備或額外勞動力的需求，進一步加速了市場成長。此外，液體疫苗的便利性和可靠性有助於其在家禽業的廣泛採用，因為家禽養殖戶正在尋求實用的解決方案來保護其羊群免受疾病侵害，從而創造積極的市場前景。

按應用分類：

飼養員

肉雞

層

肉雞市場領先地位

報告還提供了基於應用程式的詳細市場細分和分析。這包括種雞、肉雞和蛋雞。報告稱，肉雞佔最大的市場佔有率。

肉雞是專門為肉類生產而飼養的雞，加速了市場的成長。此外，由於肉雞肉的價格實惠、多功能性和營養價值，對肉雞的需求不斷增加，也促進了市場的成長。隨著全球人口持續成長，對高效和永續蛋白質來源的需求越來越大，這使得肉雞肉成為消費者和食品產業有吸引力的選擇。此外，肉雞養殖的密集性質和大規模商業化生產需要高度重視疾病預防和生物安全，這是另一個主要的生長誘導因素。除此之外，由於飼養密度高，在密閉空間飼養的肉雞更容易感染傳染病，因此疫苗接種成為其健康管理的重要方面，從而推動了市場的成長。除此之外，與其他家禽品種（例如蛋雞（產蛋母雞））相比，肉雞的生產週期更短。這意味著在更短的時間內生產和加工更多數量的肉雞，導致對家禽疫苗的需求不斷增加，以保護這些家禽免受可能影響生產和盈利能力的潛在疾病爆發，從而創造積極的市場前景。

按最終用戶分類：

獸醫院

家禽公司

家禽疫苗接種中心

報告還提供了基於最終用戶的詳細市場細分和分析。這包括獸醫醫院、家禽公司和家禽疫苗接種中心。

獸醫院對於家禽疫苗的分發和管理至關重要。它們對於向家禽養殖戶和生產者提供醫療服務和建議至關重要。此外，他們還提供診斷疾病、開出合適疫苗以及對家禽進行疫苗接種等方面的專業知識，從而促進市場成長。這些機構是值得信賴的資訊來源，對於促進家禽養殖戶採用疫苗接種做法至關重要。

此外，家禽公司，包括商業家禽養殖場和綜合家禽公司，是家禽疫苗的重要消費者。這些公司管理著大規模的家禽經營，並在確保雞群的健康和生產力方面投入了大量資金。除此之外，疫苗接種是其疾病預防和生物安全策略的一個組成部分，因為它有助於保護整個家禽族群免受傳染病的侵害，從而為市場成長提供積極的推動力。家禽公司批量採購疫苗是為了對其龐大的雞群進行免疫，並最大限度地降低疾病爆發的風險，疾病爆發可能導致大量生產損失，從而影響市場成長。

除此之外，家禽疫苗接種中心是專門為家禽注射疫苗的專門設施。這些中心可能由私人實體或政府機構營運。它們滿足了小規模家禽養殖戶和放養家禽飼養者的需求，他們可能無法進入獸醫院或缺乏疫苗接種程序的專業知識，從而加速市場成長。家禽疫苗接種中心提供方便的疫苗接種、疫苗接種服務並協助實施適當的疫苗接種計劃，以確保家禽的健康和福祉。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美在市場上表現出明顯的主導地位

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

北美的發展得益於先進的家禽養殖方法、強力的生物安全措施以及家禽養殖戶對疾病預防的高度認知，從而影響了市場的成長。此外，美國和加拿大是家禽疫苗需求不斷成長的主要推動者，因為這些國家擁有完善的家禽業，注重現代生產技術和嚴格的生物安全標準，加速了市場成長。此外，廣泛採用先進的疫苗接種計劃對於保護家禽群免受傳染病、確保持續可靠的家禽產品供應以滿足消費者需求至關重要，這是另一個主要的成長誘導因素。

此外，在歐洲市場，英國、德國、法國、荷蘭等國家家禽業發達，優先透過疫苗接種預防疾病，進而促進了市場成長。同時，在亞太市場，中國、印度和巴西等國家的家禽生產和消費正大幅成長。隨著這些地區家禽養殖活動的增加，對家禽疫苗的需求不斷成長，以降低疾病風險並確保家禽群的健康和生產力，從而創造了積極的市場前景。

競爭格局：

如今，市場上的主要參與者正在實施各種策略，以鞏固自己的地位並獲得行業競爭優勢。他們正在投資研發 (R&D)，以開發先進、更有效的家禽疫苗，並探索新技術和創新方法，以提高疫苗的功效、安全性和免疫力持續時間。此外，公司正在與研究機構、大學和家禽協會等其他行業利益相關者建立策略合作和夥伴關係，使公司能夠站在疫苗開發的最前沿並在競爭中保持領先地位。除此之外，主要參與者正在迎合更廣泛的家禽疾病和物種，並透過推出針對特定病原體的新疫苗和採用更個人化的方法來應對區域疾病挑戰來擴大其產品組合。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

AniCon Labor GmbH（SAN 集團）Biovac Ltd.

勃林格殷格翰國際股份有限公司

塞瓦聖動物

埃蘭科

海絲特生物科學有限公司

默克公司

菲布羅動物保健公司

印度文克斯

碩騰公司

本報告回答的關鍵問題

2022年全球家禽疫苗市場規模是多少
2023-2028年全球家禽疫苗市場的預期成長率是多少
COVID-19 對全球家禽疫苗市場有何影響
推動全球家禽疫苗市場的關鍵因素是什麼
根據該疾病，全球家禽疫苗市場的細分如何
根據產品，全球家禽疫苗市場的細分如何
根據劑型，全球家禽疫苗市場的細分如何
根據應用，全球家禽疫苗市場的細分如何
全球家禽疫苗市場的重點區域有哪些
10. 全球家禽疫苗市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

2022年全球家禽疫苗市場規模有多大？
2023-2028年全球家禽疫苗市場的預期成長率是多少？
COVID-19 對全球家禽疫苗市場有何影響？
推動全球家禽疫苗市場的關鍵因素是什麼？
全球家禽疫苗市場因該疾病而出現怎樣的分化？
根據產品，全球家禽疫苗市場的細分如何？
根據劑型，全球家禽疫苗市場的細分如何？
根據應用，全球家禽疫苗市場的細分如何？
全球家禽疫苗市場的重點區域有哪些？
全球家禽疫苗市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 12 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 15 章：價格分析

第16章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- AniCon Labor GmbH (SAN Group)
- Biovac Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco
- Hester Biosciences Limited
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Venkys India
- Zoetis Inc.

簡介目錄圖表

Product Code: SR112023A4547

Abstract

The global poultry vaccines market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.32% during 2022-2028. The growing awareness of disease prevention among poultry, the increasing demand for safe and disease-free poultry products, and the continuous technological advancements in vaccine development to ensure sustainable production are major factors driving the market growth.

Poultry vaccines are biological products specifically designed to protect domestic birds, such as chickens, ducks, and turkeys, from infectious diseases. It is formulated to trigger an immune response in birds, enabling them to develop immunity against specific pathogens, including viruses and bacteria. The vaccination process can be administered through different routes, such as injection, aerosol, or in the drinking water of the birds. Vaccination programs are customized to the specific disease risks prevalent in a region, and they are an integral part of biosecurity measures on poultry farms. Additionally, farmers can effectively mitigate disease outbreaks and ensure the sustainable and safe production of poultry products, by utilizing appropriate poultry vaccines. Nowadays, poultry vaccines are essential in maintaining the health and welfare of poultry populations.

The market is primarily driven by the rising demand for biological products. In addition, the escalating demand for poultry products, including meat and eggs led to increased poultry production, thus influencing the market growth. In line with this, the growing poultry populations are necessitating the use of vaccines to protect the birds and maintain production levels, thus contributing to market growth. Moreover, the growing awareness among poultry farmers and producers about the importance of preventive healthcare measures, including vaccination, to ensure the well-being and productivity of their flocks represents another major growth-inducing factor. Along with this, vaccination is considered a cost-effective and efficient method to control and prevent the spread of infectious diseases, reducing the need for antibiotics and other treatments, thus propelling market growth. Besides this, the implementation of several government policies emphasizing the importance of food safety and animal welfare are accelerating the market growth. Furthermore, advancements in vaccine technology and research led to the development of more effective and targeted vaccines, improving their efficacy and safety profiles, thus creating a positive market outlook.

Poultry Vaccines Market Trends/Drivers:

The increasing poultry consumption

The rising demand for poultry products, such as chicken, meat, and eggs is influencing the market growth. In addition, the growing population, rapid urbanization, busy lifestyles of individuals are escalating the demand for poultry products, thus contributing to the market growth. Moreover, poultry farmers are turning to vaccination as a preventive measure to protect their flocks and ensure a steady supply of safe and disease-free products representing another major growth-inducing factor. Besides this, vaccines offer an effective and efficient way to protect poultry from infectious diseases, reducing the likelihood of outbreaks and associated production losses, thus accelerating market growth. Along with this, farmers can enhance bird health and productivity, leading to improved efficiency and profitability in the poultry industry by immunizing their flocks, thus propelling market growth. Apart from this, the rising poultry consumption has led to increased international trade of poultry and poultry products, thus propelling market growth.

The growing awareness regarding disease prevention

The growing incidences of infectious diseases in poultry populations are resulting in the widespread adoption of vaccines by farmers and producers to implement preventive measures to protect their flocks, thus influencing market growth. Moreover, farmers are increasingly investing in vaccination programs to safeguard their investments, control disease, and help reduce the incidence and severity of infectious diseases in poultry representing another major growth-inducing factor. Besides this, farmers can prevent disease spread and minimize production losses, ensuring a consistent supply of healthy poultry products to meet consumer demands by immunizing their flocks, thus accelerating market growth. Along with this, the increasing health-conscious and escalating demand for safe and high-quality food products is contributing to the production of safe and wholesome poultry products with the help of vaccines, thus propelling market growth. Furthermore, the growing awareness among consumers about the benefits of vaccinated poultry further drives the demand for poultry vaccines, encouraging producers to prioritize vaccination as a critical aspect of their disease prevention strategies.

The emerging technological advancements in vaccine development

The development of modern vaccines allows the production of vaccines with improved efficacy and longer-lasting immunity, providing better protection against numerous poultry diseases, thus contributing to market growth. Moreover, the continuous development in biotechnology, innovative approaches, and techniques are leading to the creation of more effective, safe, and targeted poultry vaccines representing another major growth-inducing factor. Besides this, the extensive advancements in vaccine delivery systems, such as adjuvants and vector-based vaccines, poultry vaccines can now trigger a more robust and specific immune response thus accelerating the market growth. Along with this, these breakthroughs led to the development of customized vaccines that can address the specific needs of various poultry species and regional disease challenges, thus propelling market growth. Furthermore, advancements in vaccine formulation led to the creation of more stable and temperature-tolerant vaccines, enhancing their shelf life and reducing the need for cold chain storage and transportation leading to easier distribution and accessibility of vaccines to poultry farmers, especially in remote or resource-constrained regions, thus creating a positive market outlook.

Poultry Vaccines Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global poultry vaccines market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on disease, product, dosage form, application and end user.

Breakup by Disease:

Infectious Bronchitis

Avian Influenza

Newcastle Disease

Marek's Disease

Others

Newcastle disease represents the most common disease

The report has provided a detailed breakup and analysis of the market based on the disease. This includes infectious bronchitis, avian influenza, newcastle disease, marek's disease, and others. According to the report, Newcastle disease accounted for the largest market share.

Newcastle disease (ND) is a highly contagious viral disease that affects various avian species, including chickens, turkeys, and pigeons, leading to severe economic losses in the poultry industry. In addition, newcastle disease is a primary concern for poultry farmers and producers due to rapid transmission and devastating impact on poultry flocks, thus influencing the market growth. Also, outbreaks of ND can result in high mortality rates, reduced egg production, and decreased feed conversion efficiency, leading to substantial financial losses for the poultry industry, thus augmenting market growth. Along with this, vaccination is essential for preventive measures for poultry producers, to help build immunity against the virus, reduce the severity of infections, and minimize the spread of the disease among flocks, thus propelling the market growth. Besides this, the regular and timely vaccination of poultry populations is essential to protect against ND outbreaks and maintain flock health, thus accelerating market growth. Apart from this, poultry farmers are relying on these vaccines to ensure the well-being of their flocks, secure their investments, and maintain a steady supply of disease-free poultry products to meet consumer demands, thus providing a positive thrust to the market growth.

Breakup by Product:

Recombinant Vaccine

Live Attenuated Vaccine

Inactivated Vaccine

Subunit Vaccine

Others

Live attenuated vaccine represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes recombinant vaccine, live attenuated vaccine, inactivated vaccine, subunit vaccine, and others. According to the report, live attenuated vaccines accounted for the largest market share.

Live attenuated vaccines are developed from weakened forms of pathogens that retain their ability to induce an immune response in the host without causing severe disease, thus contributing to market growth. Additionally, live attenuated vaccines have superior efficacy in providing long-lasting immunity against numerous poultry diseases, thus influencing market growth. These vaccines elicit humoral and cell-mediated immune responses, offering robust protection to poultry flocks. Moreover, live attenuated vaccines mimic natural infections, leading to a comprehensive and sustained immune defense, and can address several poultry diseases, including avian influenza, Newcastle disease, and infectious bronchitis representing another major growth-inducing factor. Besides this, live attenuated vaccines' ability to confer cross-protection against different strains of pathogens adds to their appeal among poultry farmers and producers, thus accelerating the market growth. Apart from their efficacy, live attenuated vaccines are generally cost-effective, making them an attractive choice for large-scale poultry production, thus propelling the market growth.

Breakup by Dosage Form:

Liquid Vaccine

Freeze Dried Vaccine

Liquid vaccine presently accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the dosage form. This includes liquid vaccines and freeze-dried vaccines. According to the report, liquid vaccine accounted for the largest market share.

Liquid vaccines are known for their ease of administration and can be delivered through drinking water or by subcutaneous or intramuscular injection, making the vaccination process more straightforward and efficient. In addition, the ease of administration is particularly essential when vaccinating large flocks, as it minimizes the time and effort required for vaccination procedures, thus augmenting the market growth. Moreover, liquid vaccines offer better homogeneity and consistency in dosing, which are well-mixed in the vaccine solution, ensuring that each bird receives an accurate and uniform dose of the vaccine representing another major growth-inducing factor. This consistency is essential for achieving optimal immunization levels across the entire poultry population and maximizing the vaccine's efficacy.

Besides this, liquid vaccines can be more cost-effective than other dosage forms, as it involves lower manufacturing costs, and their efficient administration reduces the need for specialized equipment or additional labor, further accelerating the market growth. Furthermore, the convenience and reliability of liquid vaccines are contributing to their widespread adoption in the poultry industry as poultry farmers seek practical solutions to protect their flocks from diseases thus creating a positive market outlook.

Breakup by Application:

Breeder

Broiler

Layer

Broiler holds the leading position in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes breeder, broiler, and layer. According to the report, broilers accounted for the largest market share.

Broilers are chickens that are specifically raised for meat production thus accelerating the market growth. In addition, the escalating demand for broiler meat due to its affordability, versatility, and nutritional value is contributing to the market growth. As the global population continues to grow, there is a higher need for efficient and sustainable protein sources, making broiler meat an attractive option for consumers and food industries. Moreover, the intensive nature of broiler farming, with large-scale commercial production, necessitates a strong focus on disease prevention and biosecurity representing another major growth-inducing factor. Along with this, broilers raised in confined spaces are more susceptible to infectious diseases due to high stocking densities, making vaccination an essential aspect of their health management is propelling the market growth. Besides this, broilers have a shorter production cycle compared to other poultry species, such as layers (egg-laying hens). This means that a larger number of broilers are produced and processed within a shorter timeframe, leading to an escalating demand for poultry vaccines to protect these birds from potential disease outbreaks that could impact production and profitability, thus creating a positive market outlook.

Breakup by End User:

Veterinary Hospitals

Poultry Firm

Poultry Vaccination Center

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes veterinary hospitals, poultry firm, and poultry vaccination center.

Veterinary hospitals are essential in the distribution and administration of poultry vaccines. They are essential in providing medical care and advice to poultry farmers and producers. In addition, they offer expertise in diagnosing diseases, prescribing suitable vaccines, and administering vaccinations to poultry flocks, thus contributing to the market growth. These establishments act as trusted sources of information and are pivotal in promoting the adoption of vaccination practices among poultry farmers.

Moreover, poultry firms, including commercial poultry farms and integrated poultry companies, are significant consumers of poultry vaccines. These firms manage large-scale poultry operations and are highly invested in ensuring the health and productivity of their flocks. Along with this, vaccination is an integral part of their disease prevention and biosecurity strategies, as it helps protect the entire poultry population from infectious diseases, thus providing a positive thrust to the market growth. Poultry firms procure vaccines in bulk to immunize their vast flocks and minimize the risk of disease outbreaks that could lead to substantial production losses, thus influencing the market growth.

Besides this, poultry vaccination centers are specialized facilities dedicated to administering vaccines to poultry. These centers may be operated by private entities or government agencies. They cater to the needs of small-scale poultry farmers and backyard poultry keepers who may not have access to veterinary hospitals or lack expertise in vaccination procedures, thus accelerating the market growth. Poultry vaccination centers provide convenient access to vaccines, offer vaccination services, and assist in implementing proper vaccination schedules to ensure the health and well-being of the birds.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is driven by the presence of advanced poultry farming practices, robust biosecurity measures, and a high level of awareness about disease prevention among poultry farmers, thus influencing market growth. In addition, the United States and Canada are the major contributors to the escalating demand for poultry vaccines, as these countries boast well-established poultry industries with a focus on modern production techniques and stringent biosecurity standards, thus accelerating market growth. Moreover, the widespread adoption of advanced vaccination programs is essential in protecting poultry flocks from infectious diseases, ensuring a continuous and reliable supply of poultry products to meet consumer demands, representing another major growth-inducing factor.

Besides this, in Europe market, countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed poultry industries that prioritize disease prevention through vaccination, thus augmenting market growth. Along with this, in the Asia Pacific market, countries such as China, India, and Brazil are witnessing substantial growth in poultry production and consumption. As these regions experience an increase in poultry farming activities, there is a growing demand for poultry vaccines to mitigate disease risks and ensure the health and productivity of poultry flocks, thus creating a positive market outlook.

Competitive Landscape:

Nowadays, key players in the market are implementing various strategies to strengthen their position and gain a competitive edge in the industry. They are investing in research and development (R&D) to develop advanced and more effective poultry vaccines and exploring new technologies and innovative approaches to enhance vaccine efficacy, safety, and duration of immunity. Moreover, companies are forming strategic collaborations and partnerships with other industry stakeholders, such as research institutions, universities, and poultry associations, allowing companies to stay at the forefront of vaccine development and stay ahead of the competition. Besides this, key players are catering to a broader range of poultry diseases and species and expanding their product portfolios by introducing new vaccines targeting specific pathogens and adopting a more personalized approach to address regional disease challenges.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AniCon Labor GmbH (SAN Group) Biovac Ltd.

Boehringer Ingelheim International GmbH

Ceva Sante Animale

Elanco

Hester Biosciences Limited

Merck & Co. Inc.

Phibro Animal Health Corporation

Venkys India

Zoetis Inc.

Recent Developments:

In January 2020, Boehringer Ingelheim International GmbH introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). They produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

In October 2022, Zoetis Inc. launched Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that offers early/robust protection against infectious bursal, Marek's, and Newcastle disease viruses with one dose, while expanding its poultry vaccine portfolio.

In April 2022, Elanco, in collaboration with Ginkgo Bioworks, introduced a new animal healthcare company called BiomEdit to develop nutritional products, drugs, and disease-monitoring methods for livestock which aim to address antibiotic resistance and improve sustainability.

Key Questions Answered in This Report

1. What was the size of the global poultry vaccines market in 2022?
2. What is the expected growth rate of the global poultry vaccines market during 2023-2028?
3. What has been the impact of COVID-19 on the global poultry vaccines market?
4. What are the key factors driving the global poultry vaccines market?
5. What is the breakup of the global poultry vaccines market based on the disease?
6. What is the breakup of the global poultry vaccines market based on the product?
7. What is the breakup of the global poultry vaccines market based on the dosage form?
8. What is the breakup of the global poultry vaccines market based on the application?
9. What are the key regions in the global poultry vaccines market?
10. Who are the key players/companies in the global poultry vaccines market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Poultry Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Disease

6.1 Infectious Bronchitis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Avian Influenza
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Newcastle Disease
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Marek's Disease
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Product

7.1 Recombinant Vaccine
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Live Attenuated Vaccine
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Inactivated Vaccine
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Subunit Vaccine
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Dosage Form

8.1 Liquid Vaccine
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Freeze Dried Vaccine
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Application

9.1 Breeder
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Broiler
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Layer
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by End User

10.1 Veterinary Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Poultry Firm
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Poultry Vaccination Center
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 AniCon Labor GmbH (SAN Group)
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 Biovac Ltd.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Boehringer Ingelheim International GmbH
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Ceva Sante Animale
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 Elanco
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
- 16.3.6 Hester Biosciences Limited
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
- 16.3.7 Merck & Co. Inc.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Phibro Animal Health Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Venkys India
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
- 16.3.10 Zoetis Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Poultry Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Poultry Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Poultry Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Poultry Vaccines Market: Breakup by Disease (in %), 2022
Figure 5: Global: Poultry Vaccines Market: Breakup by Product (in %), 2022
Figure 6: Global: Poultry Vaccines Market: Breakup by Dosage Form (in %), 2022
Figure 7: Global: Poultry Vaccines Market: Breakup by Application (in %), 2022
Figure 8: Global: Poultry Vaccines Market: Breakup by End User (in %), 2022
Figure 9: Global: Poultry Vaccines Market: Breakup by Region (in %), 2022
Figure 10: Global: Poultry Vaccines (Infectious Bronchitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Poultry Vaccines (Infectious Bronchitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Poultry Vaccines (Avian Influenza) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Poultry Vaccines (Avian Influenza) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Poultry Vaccines (Newcastle Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Poultry Vaccines (Newcastle Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Poultry Vaccines (Marek's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Poultry Vaccines (Marek's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Poultry Vaccines (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Poultry Vaccines (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Poultry Vaccines (Recombinant Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Poultry Vaccines (Recombinant Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Poultry Vaccines (Live Attenuated Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Poultry Vaccines (Live Attenuated Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Poultry Vaccines (Inactivated Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Poultry Vaccines (Inactivated Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Poultry Vaccines (Subunit Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Poultry Vaccines (Subunit Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Poultry Vaccines (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Poultry Vaccines (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Poultry Vaccines (Liquid Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Poultry Vaccines (Liquid Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Poultry Vaccines (Freeze Dried Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Poultry Vaccines (Freeze Dried Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Poultry Vaccines (Breeder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Poultry Vaccines (Breeder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Poultry Vaccines (Broiler) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Poultry Vaccines (Broiler) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Poultry Vaccines (Layer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Poultry Vaccines (Layer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Poultry Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Poultry Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Poultry Vaccines (Poultry Firm) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Poultry Vaccines (Poultry Firm) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Poultry Vaccines (Poultry Vaccination Center) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Poultry Vaccines (Poultry Vaccination Center) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: North America: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: North America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: United States: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: United States: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Canada: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Canada: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Asia-Pacific: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Asia-Pacific: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: China: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: China: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Japan: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Japan: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: India: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: India: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: South Korea: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: South Korea: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Australia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Australia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Indonesia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Indonesia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Europe: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Europe: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Germany: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Germany: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: France: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: France: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: United Kingdom: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: United Kingdom: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Italy: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Italy: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Spain: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Spain: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Russia: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Russia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Latin America: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Latin America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Brazil: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Brazil: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Mexico: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Mexico: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Middle East and Africa: Poultry Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Middle East and Africa: Poultry Vaccines Market: Breakup by Country (in %), 2022
Figure 94: Middle East and Africa: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Global: Poultry Vaccines Industry: SWOT Analysis
Figure 96: Global: Poultry Vaccines Industry: Value Chain Analysis
Figure 97: Global: Poultry Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Poultry Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Poultry Vaccines Market Forecast: Breakup by Disease (in Million US$), 2023-2028
Table 3: Global: Poultry Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Poultry Vaccines Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
Table 5: Global: Poultry Vaccines Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Poultry Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Poultry Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Poultry Vaccines Market: Competitive Structure
Table 9: Global: Poultry Vaccines Market: Key Players

02-2729-4219

+886-2-2729-4219